REVIVA PHARMACEUTICALS
Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. Reviva’s current pipeline focuses on the central nervous system, respiratory, and metabolic diseases. Reviva is using chemical genomics driven technology platform and proprietary chemistry to develop new medicines. Reviva’s pipeline currently has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the United States (U.S.), Europe, and several other countries.
REVIVA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Genetics Health Care Pharmaceutical
Founded:
2006-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.revivapharma.com
Total Employee:
11+
Status:
Active
Contact:
+114088161470
Total Funding:
41.41 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API WordPress Apache Wordpress Plugins Microsoft Exchange Online IPv6 Cloudflare JS
Similar Organizations
Afferent Pharmaceuticals
Afferent Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines to treat chronic pain.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
American Family Care
American Family Care is a medical practice offering occupational health services.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Harbour Biomed
Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.
Imago Pharmaceuticals
Imago Pharmaceuticals is a virtual, privately held company developing JNK-directed novel therapies.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
New River Pharmaceuticals Inc
New River Pharmaceuticals is a specialty pharmaceutical company developing novel pharmaceuticals.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Pacira Pharmaceuticals
Pacira Pharmaceuticals is a specialty pharmaceutical company dedicated to postsurgical innovation.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Xenon Pharmaceuticals
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
Current Advisors List
Board_member
2017-05-01
Current Employees Featured
Laxminarayan Bhat President and CEO @ Reviva Pharmaceuticals
President and CEO
2006-01-01
Founder
Stock Details
Official Site Inspections
http://www.revivapharma.com Semrush global rank: 4.3 M Semrush visits lastest month: 2.67 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Reviva Pharmaceuticals"
Corporate Presentation - Reviva Pharmaceuticals
3 days ago Reviva Pharmaceuticals Holdings, Inc. 10080 N Wolfe Road, Suite SW3-200. Cupertino, CA 95014. Phone: +1.408.501.8881 Email: [email protected]See details»
Home - Reviva Pharmaceuticals
Mar 31, 2025 Our lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple unmet neuropsychiatric indications including schizophrenia, bipolar disorder, major depressive disorder, behavioral and …See details»
Investors - Reviva Pharmaceuticals
6 days ago Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is a clinical-stage pharmaceutical company that discovers, develops and seeks to commercialize next …See details»
Reviva Pharmaceuticals - LinkedIn
NASDAQ: RVPH Reviva Pharmaceuticals, Inc., (Reviva) headquartered in Santa Clara, California, is a publicly traded, late-stage clinical development pharmaceutical company.See details»
Reviva Pharmaceuticals - Crunchbase Company Profile …
Contact Email info.rp@revivapharma.com Phone Number +114088161470 Reviva Pharmaceuticals is a clinical-stage biopharmaceutical company that …See details»
Reviva Pharmaceuticals Holdings (RVPH) Company Profile
May 5, 2025 10080 N. Wolfe Road, Suite SW3-200 Cupertino, California 95014 United StatesSee details»
Reviva Pharmaceuticals - The Org
Reviva Pharmaceuticals, Inc., (Reviva) headquartered in Santa Clara, California, is a publicly traded, late-stage clinical development pharmaceutical company. Reviva is developing a …See details»
Reviva Pharmaceuticals - Craft
Oct 29, 2024 Reviva Pharmaceuticals is a pharmaceutical company. It develops a portfolio of internally discovered therapies that address unmet medical needs in the areas of central …See details»
Reviva Pharmaceuticals, Inc. (Reviva Pharmaceuticals, Inc.) - 药物管 …
The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Corporate Contact:Reviva …See details»
Reviva Pharmaceuticals, Inc. Company Profile | Cupertino, CA ...
Find company research, competitor information, contact details & financial data for Reviva Pharmaceuticals, Inc. of Cupertino, CA. Get the latest business insights from Dun & Bradstreet.See details»
Reviva Pharmaceuticals Holdings, Inc. (Reviva Pharmaceuticals …
Corporate Contact:Reviva Pharmaceuticals Holdings, Inc.Laxminarayan Bhat, PhDwww.revivapharma.com Investor Relations Contact:LifeSci Advisors, LLCBruce …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 9, 2024 Reviva Pharmaceuticals contact info: Phone number: (408) 501-8881 Website: www.revivapharma.com What does Reviva Pharmaceuticals do? Reviva Pharmaceuticals Inc …See details»
Reviva Pharmaceuticals Holdings, Inc. (RVPHW) Company Profile ...
Mar 7, 2025 10080 N. Wolfe Road, Suite SW3-200 Cupertino, California 95014 United StatesSee details»
Reviva Pharmaceuticals Management Team | Org Chart
Reviva Pharmaceuticals employs 16 employees. The Reviva Pharmaceuticals management team includes Narayan Prabhu (Chief Financial Officer), Richard Margolin (Member, Board of …See details»
About us - Reviva Pharmaceuticals
Our lead drug candidate, brilaroxazine, is in clinical development for multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder, major depressive disorder (MDD), …See details»
Reviva Pharmaceuticals - VentureRadar
Website: http://www.revivapharma.com. Develops next-generation therapeutics targeting central nervous system, respiratory, and metabolic diseases, with a current ...See details»
Reviva to Present Late-Breaking Poster on the RECOVER Long …
CUPERTINO, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company …See details»
Press Releases - Reviva Pharmaceuticals
6 days ago Reviva Pharmaceuticals Holdings, Inc. 10080 N Wolfe Road, Suite SW3-200. Cupertino, CA 95014. Phone: +1.408.501.8881 Email: [email protected]See details»
Reviva Pharmaceuticals Holdings Inc. - Cruelty Free Investing
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet …See details»
Reviva Reports Full Year 2024 Financial Results and Recent …
Mar 31, 2025 – Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension (OLE) trial – – Registrational Phase 3 …See details»